Search alternatives:
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
larger decrease » marked decrease (Expand Search)
latest decrease » largest decrease (Expand Search), largest decreases (Expand Search), latency decreased (Expand Search)
laser decrease » linear decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
larger decrease » marked decrease (Expand Search)
latest decrease » largest decrease (Expand Search), largest decreases (Expand Search), latency decreased (Expand Search)
laser decrease » linear decrease (Expand Search), water decreases (Expand Search), teer decrease (Expand Search)
-
141
-
142
Dose dependent changes in fluorescence and forward scatter from cyanobacteria treated with H<sub>2</sub>O<sub>2</sub>.
Published 2023“…<p>Fig 1 shows the dose dependent change in red fluorescence in one detector (652–669 nm)from a yellow green laser and green fluorescence in one detector (533–550 nm) from a violet laser for doses between 3 and 3000 μg/mL during a 3-day period (24–72 hours). …”
-
143
-
144
-
145
-
146
-
147
Changes in cyanobacteria fluorescence with 75 μg/mL H<sub>2</sub>O<sub>2</sub> for 5, 8, 17 and 24 days.
Published 2023“…<p>The data is shown with fluorescence intensity curves derived from Cytek spectra (A) and cytograms that compare the emission of green fluorescence (533–550 nm) from violet laser excitation and red fluorescence (652–669 nm) from excitation with yellow green laser (B). …”
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years
Published 2023“…There were sex differences in the annual prevalence of <em>DME/VTDR</em> and <em>any DME</em>, with males having a higher prevalence than females. Annual claims for anti-VEGF increased among those with <em>any DME</em> (327%) and <em>VTDR with DME</em> (206%); laser photocoagulation decreased among patients with <em>any DME </em>(-68%), <em>VTDR with DME </em>(-54%), and <em>VTDR without DME</em> (-62%). …”
-
159
-
160